
Merck has been hit with an antitrust action in New Jersey district court, which claimed that the company entered into an anticompetitive settlement agreement and an unlawful business arrangement in violation of antitrust and consumer protection laws in relation to two cholesterol-reducing drugs.
Biotech & Pharmaceuticals
December 13, 2023, 2:24 PM